Archive

May 2025

Browsing

NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario Securities Commission, has granted its request for a management cease trade order (‘MCTO’) effective May 8, 2025.

As previously announced on April 29, 2025, the Company applied for the MCTO due to a delay in filing its annual audited financial statements, management’s discussion and analysis and related certifications for the financial year ended December 31, 2024 (the ‘Annual Filings’) which were required to be filed by April 30, 2025.

The delay is primarily due to a restatement of certain amounts owed by the Company’s payment service providers as well as player loyalty bonuses for the prior fiscal years. During the year-end reconciliation process, the Company identified that its payment processor had deducted additional merchant fees from daily remittances, which had not been properly accounted for. Specifically, service provider fees (cost of revenue) were previously understated, while the amounts due from the payment processor and accounts receivable were overstated in the financial statements for the year ended December 31, 2023.

The Company is working diligently and expeditiously to complete the Annual Filings as soon as practicable, and currently anticipates it will be in a position to file the Annual Filings on or before May 15, 2025.

The MCTO restricts the Company’s Chief Executive Officer and the Chief Financial Officer from trading in the Company’s securities but does not affect the ability of other shareholders, including the public, to trade in securities of the Company.

About NorthStar

NorthStar proudly owns and operates NorthStar Bets, a Canadian-born casino and sportsbook platform that delivers a premium, distinctly local gaming experience. Designed with high-stakes players in mind, NorthStar Bets Casino offers a curated selection of the most popular games, ensuring an elevated user experience. Our sportsbook stands out with its exclusive Sports Insights feature, seamlessly integrating betting guidance, stats, and scores, all tailored to meet the expectations of a premium audience.

As a Canadian company, NorthStar is uniquely positioned to cater to customers who seek a high-quality product and an exceptional level of personalized service, setting a new standard in the industry. NorthStar is committed to operating at the highest level of responsible gaming standards.

NorthStar is listed in Canada on the TSX Venture Exchange (‘TSXV’) under the symbol ‘BET’ and in the United States on the OTCQB under the symbol ‘NSBBF’. For more information on the company, please visit: www.northstargaming.ca.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Information and Statements

This communication contains ‘forward-looking information’ within the meaning of applicable securities laws in Canada (‘forward-looking statements’), including without limitation, statements with respect to the following: expected performance of the Company’s business, and the timing of the release of the Company’s financial results. The foregoing is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and allowing investors and others to get a better understanding of the Company’s anticipated financial position, results of operations, and operating environment. Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘continues’, ‘forecasts’, ‘projects’, ‘predicts’, ‘intends’, ‘anticipates’ or ‘believes’, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘should’, ‘might’ or ‘will’ be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. This forward-looking information is based on management’s opinions, estimates and assumptions that, while considered by NorthStar to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such forward- looking information. Such factors include, among others, the following: risks related to the Company’s business and financial position; risks associated with general economic conditions; adverse industry risks; future legislative and regulatory developments; the ability of the Company to implement its business strategies; and those factors discussed in greater detail under the ‘Risk Factors’ section of the Company’s most recent annual information form, which is available under NorthStar’s profile on SEDAR+ at www.sedarplus.ca. Many of these risks are beyond the Company’s control.

If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking statements. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents NorthStar’s expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

For further information:

Company Contact:
Corey Goodman
Chief Development Officer 647-530-2387
investorrelations@northstargaming.ca

Investor Relations:
RB Milestone Group LLC (RBMG)
Northstar@rbmilestone.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251431

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry.

However, the sector is seeing a resurgence of optimism in 2025 on the back of various US developments.

“The psychedelic industry in 2025 will likely see significant advancements in clinical applications, particularly in treating PTSD, depression, and addiction, as research continues to validate their therapeutic potential,” Dr. Markus Ploesser, chief innovation officer at Open Mind Health, told Microdose in January.

This sentiment is underscored by a variety of recent positive developments, including the FDA’s approval of Johnson & Johnson’s (NYSE:JNJ) ketamine-derived nasal spray to combat treatment-resistant depression, and an initiative to study MDMA-assisted therapy efficacy for post-traumatic stress disorder (PTSD) and alcohol use disorder in veterans.

In addition, alternative medicine advocate Robert F. Kennedy Jr.’s appointment as head of the US Department of Health and Human Services has created potential for further policy shifts related to mental health and psychedelics research.

Combined, these factors could make 2025 a pivotal year for the industry.

Legal state psychedelics markets take shape

Psychedelic compounds remain federally illegal in the US, but some states have pursued legalization and decriminalization. In November 2020, Oregon became the first state to legalize psilocybin for therapeutic use through the Oregon Psilocybin Services Act. From 2021 to 2022, the Oregon Health Authority and the Psilocybin Advisory Board created rules for the act and began taking applications on January 2, 2023.

Oregon also decriminalized personal possession of all drugs in 2020 through the Drug Addiction Treatment and Recovery Act, which went into effect in February 2021. Many of the provisions in that bill have since been reversed, with the possession of small amounts of hard drugs like fentanyl, methamphetamine and heroin being recriminalized as of September 1, 2024. However, psilocybin remains legal for therapeutic and facilitated use.

As of the end of March, Oregon Psilocybin Services counted 374 state-wide psilocybin facilitators, 29 service centers, 10 manufacturers and 808 worker permits. Satya Therapeutics, located in Ashland, is recognized as one of the state’s most experienced and successful service providers, with roughly 40 to 50 clients serviced monthly.

Publicly traded Florida-based cannabis company Kaya Holdings (OTCQB:KAYS) was awarded a license to operate a psilocybin service center in Oregon through its Fifth Dimension Therapeutics subsidiary in May 2024. Its treatment center, called the Sacred Mushroom, opened its doors in Portland on July 2, 2024.

In 2025, industry advocates are focused on analyzing outcomes from Oregon’s psychedelics program in order to fine tune areas requiring improvement. In February, state lawmakers sought to expand psychedelic therapy through the introduction of HB 3817, which establishes an access pathway for individuals with PTSD to access ibogaine. At the time of this writing, the bill had not yet been scheduled for a public hearing or committee vote.

Despite its growth, affordability has been a barrier to the development of Oregon’s psilocybin therapy program, with sessions typically costing over US$1,500. Some communities in the state also voted to ban psilocybin and psilocybin businesses in 2024, reflecting ongoing public concerns about drug liberalization.

In Colorado, a series of legislative actions regarding psychedelic substances led to state legalization in November 2022. Proposition 122 legalized the regulated access to psilocybin and psilocin in healing centers for adults over 21, decriminalized the personal use and cultivation of these substances and established a Natural Medicine Advisory Board.

SB 23-290, signed in May 2023, amended Proposition 122’s regulations and created a legal framework for healing centers. HB 22-1344, passed in June 2022, paved the way for MDMA-assisted therapy for PTSD if federally approved.

The final rules for licensed psilocybin therapy centers were filed with the secretary of state and became effective on December 15, 2024. Colorado then began accepting applications for licenses. In March, the Department of Revenue issued its first healing center license to the Center Origin in Denver. As of May 2 of this year, there were over 50 pending applications for healing centers, cultivation facilities and manufacturers.

As the psychedelics industry begins to take shape in Colorado, Tasia Poinsatte, the state’s director of the nonprofit Healing Advocacy Fund, told Stateline that centers plan to offer sliding-scale rates and discounts for veterans, Medicaid enrollees and low-income individuals to help address the affordability problem.

New psychedelics laws and research initiatives

Apart from Oregon and Colorado, a wave of legislative activity concerning psychedelics is evident across the US, with states like Illinois, Indiana, Missouri, Maine and New York pursuing various forms of legalization, including decriminalization, research funding and regulated therapeutic programs. Additionally, several cities in Washington and Michigan have decriminalized certain substances, with Washington also considering bills to create a regulated psilocybin services market and to provide funding to study ibogaine for opioid use disorder.

Utah passed legislation in March 2024 to create a program for psilocybin and MDMA as alternative treatments at the University of Utah Health and Intermountain Health. The program began in May 2024 and will run for three years.

Multiple institutions in Maryland, Texas and North Carolina are also conducting studies to assess the efficacy of psychedelics in treating various mental health conditions.

Senate Bill 242 established a working group tasked with studying the therapeutic use of entheogens in Nevada in 2023. A recommendations report was delivered in December 2024, and has garnered support from key legislative figures.

Several cities in California have deprioritized the enforcement of laws against the personal use and possession of certain psychedelics, and the state is considering a psilocybin pilot program for veterans and first responders.

Massachusetts has multiple bills focused on decriminalization and therapeutic pilot programs. In April of this year, New Mexico’s governor signed a bill for a therapeutic psilocybin program.

Meanwhile, Rhode Island has a bill that would legalize psilocybin possession if the federal government reschedules it, and Alaska established a task force in May 2024 to prepare for potential federal legalization of psychedelic therapies.

These actions reflect a shift in psychedelics sentiment and a growing trend of exploring their therapeutic potential.

Psychedelics investing options

To track the financial health of the psychedelic industry, investors can use the Psychedelic Invest Index, which monitors publicly traded companies in the space. Some of the top stocks in the index include Pasithea Therapeutics (NASDAQ:KTTA), MindMed (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS) and Cybin (NYSEAMERICAN:CYBN), all of which are involved in developing psychedelic compounds for mental health treatments.

MindMed has developed a synthetic LSD analog, MM120, currently in Phase III trials for generalized anxiety disorder (GAD) and major depressive disorder (MDD). An oral tablet of MM120 was awarded a patent in July 2024.

Cybin has developed a proprietary deuterated psilocybin analog called CYB003, as well as CYB004, a proprietary deuterated DMT compound; both are protected by patents. The company also acquired SPL028, another deuterated DMT compound, through its merger with Small Pharma in 2023. Phase 2 CYB004 topline safety and efficacy data in GAD is expected in H1 2025. A pivotal study of CYB003 is scheduled for mid-2025.

Meanwhile, Compass Pathways’ Phase 2b randomized controlled study evaluating its synthetic psilocybin therapy, COMP360, was the most extensive psilocybin clinical trial to date. With data presented in 2022, the trial found that one 25 milligram dose of COMP360 resulted in a decline in depressive symptoms after three weeks when combined with psychological guidance, with positive effects reportedly lasting for as long as 12 weeks.

Other key players in the psychedelics market include atai Life Sciences (NASDAQ:ATAI), GH Research (NASDAQ:GHRS), Bright Minds Biosciences (NASDAQ:DRUG) and Silo Pharma (NASDAQ:SILO).

Canadian companies in this sector include Numinus Wellness (TSX:NUMI,OTCQB:MTPLF), Optimi Health (CSE:OPTI,OTCQX:OPTHF), BetterLife Pharma (CSE:BETR,OTCQB:BETRF), Pharmala Biotech (CSE:MDMA,OTCQB:MDXXF) and Restart Life Science (CSE:REST,OTC Pink:NMLSF).

Other avenues for investors include strategic investments in specialized real estate ventures.

Healing Realty Trust (HRT) specializes in acquiring healthcare infrastructure assets, focusing on developing mental and behavioral healthcare facilities. The company established preferred real estate partnership agreements with providers like NeuroSpa, Cambridge Biotherapies and Cathexis in 2024. It has also secured the first tranche of a US$25 million Series A funding round, with the funds earmarked to acquire healthcare facilities in Texas, Ohio and Connecticut.

HRT is reportedly preparing for an initial public offering, with a potential listing in late 2025 or early 2026.

Investor takeaway

Against this backdrop, the psychedelics market could see promising growth in 2025.

While challenges remain, the expansion of legalization and decriminalization, combined with ongoing research, positions the industry for growth and presents potential opportunities for investors.

Securities Disclosure: I, Meagen Seatter, hold direct investment interest in some of the companies mentioned in this article.

This post appeared first on investingnews.com

A former top aide in President Donald Trump’s first administration is arguing that Republicans raising taxes on wealthy Americans ‘makes no sense.’

Marc Short, the former chief of staff to ex-Vice President Mike Pence, was an integral part of negotiations for Trump’s 2017 Tax Cuts and Jobs Act (TCJA). He also served in Trump’s first White House as director of legislative affairs from 2017 to 2018.

‘Raising taxes on America’s highest earners and biggest job creators makes no sense. I don’t understand why there are some inside the current administration who are pushing Congress to raise the top rate, because again, these are America’s job creators,’ Short said.

‘So many small businesses file taxes as individuals. And so you’re actually going to be raising taxes on many small businesses, not just individuals.’

Congressional Republicans are working on a massive piece of legislation that Trump has dubbed his ‘big, beautiful bill,’ aimed at advancing his policies on tax, border security, immigration, energy, defense and the national debt.

The tax policy portion is expected to be the costliest, and House negotiators are working on identifying a number of areas to cut a total of at least $1.5 trillion to offset the new spending.

A source familiar with Trump’s thinking told Fox News Digital he’s considering allowing the rate on individuals making $2.5 million or more to revert from 37% to the pre-2017 39.6%. 

It will help pay for massive middle- and working-class tax cuts as well as protect Medicaid, the source said.

The TCJA lowered the tax rate for the top income bracket — currently $609,350 for single filers — to 37%, a cut that’s expiring at the end of this year.

Creating a new, higher tax bracket for people earning significantly more than that would help pay for extending the 2017 tax cuts as well as implementing Trump’s new priorities: eliminating taxes on tips, overtime pay and retirees’ Social Security checks.

But Short, who helped get the 2017 package passed, dismissed those new Trump priorities as short-sighted political sweeteners.

‘I feel like some of the administration’s new requirements are somewhat gimmicky. I’m not sure many Americans who earn their income based on tips are even paying taxes on those tips right now. And I think we should begin to extend that to say no tax on overtime,’ he said.

Short said those changes would create ‘a lot of additional hurdles for businesses to comply with.’

‘I think the no tax on Social Security, it seems like what we’re trying to do is different from 2017, when we passed the Tax Cuts and Job Act,’ he said. ‘We tried to simplify the tax code, make it flatter and fair for all Americans, as opposed to creating carve-outs for certain constituencies.’

Fox News Digital reached out to the White House for a response to Short’s remarks.

Some conservative groups like the Heritage Foundation and Americans for Prosperity are also wary of a potential tax hike for the wealthy.

Richard Stern, director of the Hermann Center for the Federal Budget at the Heritage Foundation, said the group is opposed to efforts to raise tax rates to 40% or higher.

‘Congress needs to get its fiscal house in order, but it must do so by tightening its own belt, not by forcing American taxpayers to tighten theirs. A higher top tax rate would be counterproductive, discouraging hard work and entrepreneurship,’ Stern said.

Americans for Prosperity chief government affairs officer Brent Gardner said in a statement, ‘Raising taxes on any American should be completely off the table.’

This post appeared first on FOX NEWS

Former Vice President Mike Pence has a message for his old boss.

Pence is urging President Donald Trump, under whom he served as vice president in Trump’s first administration, not to raise the tax rate on wealthy Americans.

Trump’s 2017 Tax Cuts and Jobs Act, the signature domestic achievement of his first White House term, is scheduled to expire this year if it’s not extended by Congress.

The Trump White House and some congressional Republicans for weeks have mulled letting the tax reductions on the wealthy sunset as a way to pay for the rest of the tax cuts as well as Trump’s other pricey second-term priorities. 

 

And the president, during a Wednesday phone call, pushed House Speaker Mike Johnson to raise taxes on the highest income earners and close the carried interest loophole in the reconciliation process, Fox News Digital confirmed. The development was first reported Thursday by Punchbowl News.

A source familiar with Trump’s thinking said Trump is considering allowing the rate on individuals making $2.5 million or more to increase by 2.6%, from 37% to 39.6%.

But Pence, a fiscal conservative and budget hawk during his long political career in the House of Representatives, as Indiana governor and as vice president, strongly cautioned against upping the rates on the highest earners.

‘Any suggestion that I’ve heard among some in and around the administration that we raise the top margin rate, the so-called millionaires tax, would be an enormous tax increase on small business owners across America,’ Pence said. ‘It needs to be opposed.’

And the former vice president, in an interview with Fox News Digital this week, argued that ‘the majority of people that file taxes of a million dollars are simply individuals that own businesses, and they file their taxes as an individual, but then plow that money back into their company. If you raise that top margin, it would be an enormous tax increase on small business America.’

‘Let’s make all the Trump-Pence tax cuts permanent. That’s a way to really lay a foundation to grow the economy in the days ahead,’ Pence urged.

Pence, who was interviewed in Boston after receiving the John F. Kennedy Profiles in Courage award, gave ‘President Trump all the credit in the world for an historic victory last November, and for sparing the country one more liberal Democrat administration.’

He also praised Trump ‘not only for his victory, but for securing our southern border, for restoring morale and recruitment in our military, for taking the fight to the Houthis.’

But he argued that ‘I truly do believe that some of the other steps the president is taking away from that conservative agenda should be a concern that would work against his legacy and ultimately the success of our party or our country. And so we’re going to continue to be a voice against them.

‘I really do believe that for prosperity … for the success of our country, we need to stick to those time-honored principles of strong defense, American leadership on the world stage, less government, less taxes, traditional moral values and the right to life, and I’m going to be a voice for that,’ Pence added.

This post appeared first on FOX NEWS

The Department of Justice has opened a criminal investigation into New York Attorney General Letitia James, Fox News has learned.

A source familiar with the matter confirmed that a grand jury in the Eastern District of Virginia sent out subpoenas related to accusations that James misrepresented a single-family home in Virginia as her primary residence to obtain more favorable loan terms.  

News of the federal probe follows a criminal referral from the Trump administration’s Federal Housing Finance Agency Director William Pulte, who requested the DOJ investigate James over that matter and another incident in which she allegedly misrepresented the number of livable units in a multifamily Brooklyn house to once again obtain better loan terms. 

‘These baseless and long-discredited allegations, put to rest by my April 24 letter to the Department of Justice, are suddenly back in the news just days after President Trump publicly attacked Attorney General James,’ James’ attorney, Abbe Lowell, said Thursday. 

‘This appears to be the political retribution President Trump threatened to exact that AG Bondi assured the Senate would not occur on her watch. If prosecutors are genuinely interested in the truth, we are prepared to meet false claims with facts.’

After Pulte’s criminal referral was sent to the Justice Department, specifically U.S. Attorney General Pam Bondi, Lowell followed up with his own letter to Bondi and the Justice Department, accusing the president of seeking ‘political retribution.’ 

James has been part of a group of Democratic attorneys general who have sued to halt many of Trump’s orders during his first few months in the Oval Office. 

Additionally, James was the catalyst behind Trump becoming the first U.S. president sentenced as a felon. She was the lead prosecutor in a case she brought against Trump and the Trump Organization that alleged Trump and his company falsified business records to obtain more favorable loan terms.

Trump was convicted on 34 felony counts of falsifying business records and was ordered to pay $350 million in penalties and is appealing the conviction.

‘The stunning hypocrisy of President Trump’s complaint that the Justice Department had been ‘politicized’ and ‘weaponized’ against him is laid bare as he and others in his administration are now asking you to undertake the very same practice,’ Lowell wrote in his letter to Bondi.

Lowell, in his letter, pointed to instances when Trump has called for revenge and instances when the president has personally attacked James. 

Lowell also responded to the allegations, including the claim James listed a home in Virginia as her primary residence while serving as a state official in New York. According to Lowell, James had no intention of using the property as a primary residence, and her indication of this in a power-of-attorney letter was a mistake. Lowell pointed out there were other documents in which James indicated to her lender that the Virginia home would not be her primary residence. 

James is also accused of fraud for allegedly inflating the number of livable units in a multifamily Brooklyn home to receive better interest rates. Lowell accuses Pulte of disregarding updated documentation listing the residence as a four-unit multifamily residence and instead pointing to a certificate of occupancy from 2001. 

This post appeared first on FOX NEWS

President Donald Trump said he does not know his new nominee for U.S. surgeon general, telling reporters Thursday that he relied upon the recommendation of Health and Human Services Secretary Robert F. Kennedy Jr.

Trump withdrew the nomination of his first pick for surgeon general, Dr. Janette Nesheiwat, this week and instead nominated Dr. Casey Means. The president, upon announcing her nomination, said she has ‘impeccable ‘MAHA’ credentials.’ 

When asked Thursday about Means and why he tapped her for the role, the president said Kennedy recommended her. 

‘Because Bobby thought she was fantastic, brilliant woman who went through Stanford — wanted to be academic instead of physician,’ the president said. 

‘I don’t know her, I listened to Bobby,’ Trump added. ‘I think she’ll be great.’ 

Means, a vocal ‘Make America Healthy Again’ proponent, played a significant role in helping shape the administration’s agenda surrounding health alongside her brother, Calley Means. 

She has made a name for herself as a wellness influencer alongside her brother. In 2024, both Casey and Calley co-wrote a book about the chronic disease epidemic titled ‘Good Energy,’ and Casey is also the co-founder of a health-tech company called Levels.

Calley Means was previously tapped by the administration to serve as a top special advisor to Kennedy. 

It is unclear why Nesheiwat’s nomination was pulled. Fox News Digital reached out to the White House for more information and did not immediately receive a response. 

Meanwhile, in a follow-up post on X, Nesheiwat also said she was ‘looking forward’ to continuing to support Trump while working closely with Kennedy ‘in a senior policy role.’ 

‘My focus continues to be on improving the health and well-being of all Americans, and that mission hasn’t changed,’ Nesheiwat concluded in her public social media remarks.  

Nesheiwat is the sister-in-law of recently fired National Security Advisor Michael Waltz, whom the president indicated he will now be nominating to be the next ambassador to the United Nations after dropping his initial nominee, New York GOP Congresswoman Elise Stefanik. 

This post appeared first on FOX NEWS

Amid firings and government shake-ups, the Trump administration has repeatedly been assigning additional job roles to Cabinet members and other officials, Fox News Digital found. 

Secretary of State Marco Rubio was charged on May 1 with serving as Trump’s national security advisor after the president announced he had nominated former National Security Council chief Mike Waltz to serve as the U.S. ambassador to the United Nations. 

Rubio’s roles in the administration now include leading the State Department; serving as acting archivist of the United States after Trump ousted a Biden-era appointee; serving as acting administrator of the U.S. Agency for International Development as the admin works to dissolve the independent agency by September; and taking the helm as the interim national security advisor. 

But Rubio is not alone in taking on multiple roles within Trump’s second administration. Fox News Digital looks back on the various Trump Cabinet members and officials who are wearing multiple hats as the president works to realign the federal government to track with his ‘America First’ policies. 

Marco Rubio 

Rubio and the Trump administration have come under fire from Democrats for the secretary of state holding multiple high-profile roles in the second administration, including Democrats sounding off on the national security council shake-up on Sunday news shows. 

‘There’s no way he can do that and do it well, especially since there’s such incompetence over at DOD with Pete Hegseth being secretary of defense and just the hollowing out of the top leadership,’ Illinois Democrat Sen. Tammy Duckworth said on CBS’s ‘Face the Nation.’ ‘There’s no way he can carry all that entire load on his own.’

‘I don’t know how anybody could do these two big jobs,’ Democrat Virginia Sen. Mark Warner said Sunday on CNN’s ‘State of the Union.’

When asked about the trend of Trump officials wearing multiple work hats, the White House reflected in comment to Fox News Digital on former President Joe Biden’s ‘disaster of a Cabinet.’ 

‘Democrats cheered on Joe Biden’s disaster of a Cabinet as it launched the botched Afghanistan withdrawal, opened the southern border to migrant criminals, weaponized the justice system against political opponents, and more,’ White House spokesperson Anna Kelly told Fox News Digital. ‘President Trump has filled his administration with many qualified, talented individuals he trusts to manage many responsibilities.’ 

The Trump administration has previously brushed off concern over Rubio holding multiple roles, most notably juggling both his State Department leadership and serving as acting national security advisor. Similarly, former President Richard Nixon in 1973 named then-National Security Advisor Henry Kissinger to simultaneously serve as secretary of state. 

‘You need a team player who is very honest with the president and the senior team, not someone trying to build an empire or wield a knife or drive their own agenda. He is singularly focused on delivering the president’s agenda,’ an administration official told Politico. 

Rubio’s multiple national security roles come as war continues between Russia and Ukraine, Israel and Gaza, and recently launched attacks from India on Pakistan. 

‘I am monitoring the situation between India and Pakistan closely,’ Rubio said in a Tuesday X post. ‘I echo @POTUS’s comments earlier today that this hopefully ends quickly and will continue to engage both Indian and Pakistani leadership towards a peaceful resolution.’

As Rubio juggles multiple roles, the Trump administration’s foreign policies have closely involved special envoys, most notably Steve Witkoff, Trump’s special envoy to the Middle East.

Witkoff is a former real estate tycoon and longtime ally of Trump’s whose focus in the Trump administration has been on negotiating with Russia amid its war against Ukraine and leading talks with Iran regarding its nuclear program. Witkoff was notably credited with helping secure the release of U.S. schoolteacher Marc Fogel from a Russian prison in February.

Fox News Digital reached out to the State Department for comment on Rubio’s multiple roles but did not receive a response. 

Kash Patel

FBI Director Kash Patel, who railed against the ‘deep state’ and vowed to strip corruption from the federal law enforcement agency ahead of his confirmation, was briefly charged with overseeing the of the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) in February after the Biden-era director resigned in January. 

Patel was later replaced by Secretary of the Army Daniel Driscoll as acting ATF director in a job change that was publicly reported in April. 

‘Director Kash Patel was briefly designated ATF director while awaiting Senate confirmations, a standard, short-term move. Dozens of similar re-designations have occurred across the federal government,’ the White House told Reuters in April. ‘Director Patel is now excelling in his role at the FBI and delivering outstanding results.’

Daniel Driscoll 

Driscoll was sworn in as the 26th secretary of the Army in February. The secretary of the army is a senior-level civilian official charged with overseeing the management of the Army and also acts as an advisor to the secretary of defense in matters related to the Army. 

It was reported in April that Driscoll was named acting ATF director, replacing Patel in that role. 

‘Mr. Driscoll is responsible for the oversight of the agency’s mission to protect communities from violent criminals, criminal organizations, and the illegal trafficking of firearms, explosives, and contraband. Under his leadership, the ATF works to enforce federal laws, ensure public safety, and provide critical support in the investigation of firearms-related crimes and domestic and international criminal enterprises,’ his ATF biography reads. 

Ahead of Trump taking office, Republican Reps. Eric Burlison of Missouri and Lauren Boebert of Colorado introduced legislation to abolish the ATF, saying the agency has worked to strip Second Amendment rights from U.S. citizens. 

The ATF has been tasked with assisting the Department of Homeland Security in its deportation efforts under the Trump administration. 

Doug Collins 

Former Georgia Republican Rep. Doug Collins was sworn-in as the Trump administration’s secretary of Veterans Affairs in February, a Cabinet-level position tasked with overseeing the department and its mission of providing health, education and financial benefits to military veterans. 

Days after his confirmation as VA secretary, Trump tapped Collins to temporarily lead two oversight agencies: the Office of Government Ethics and the Office of Special Counsel. 

The Office of Government Ethics is charged with overseeing the executive branch’s ethics program, including setting ethics standards for the government and monitoring ethics compliance across federal agencies and departments. 

The Office of Special Counsel is charged with overseeing and protecting the federal government’s merit system, most notably ensuring federal whistleblowers don’t face retaliation for sounding the alarm on an issue they’ve experienced. The office also has an established secure channel to allow federal employees to blow the whistle on alleged wrongdoing. 

The Office of Special Counsel also enforces the Hatch Act, which bans executive branch staffers, except the president and vice president, from engaging in certain forms of political activity

Russell Vought 

Trump named his former director of the Office of Management and Budget under his first administration, Russell Vought, to the same role in his second administration. Vought was confirmed as the federal government’s budget chief in February. 

Days later, Vought was also named the acting director of the Consumer Financial Protection Bureau (CFPB).  

The CFPB is an independent government agency charged with protecting consumers from unfair financial practices in the private sector. It was created in 2010 under the Obama administration after the financial crash in 2008. Democrat Massachusetts Sen. Elizabeth Warren originally proposed and advocated for the creation of the agency.

The CFPB came under fierce investigation from the Department of Government Efficiency in February, with mass terminations rocking the agency before the reduction in force initiative was tied up in court. 

Ric Grenell 

President Donald Trump’s former ambassador to Germany and acting director of national intelligence under his first term, a pair of roles held at separate times in the first administration, currently serves as president of the Kennedy Center and special presidential envoy for special missions of the United States. 

The John F. Kennedy Center for the Performing Arts serves as the national cultural center of the U.S. Trump notably serves as the center’s chair of the board, with Grenell saying the center will see a ‘golden age’ of the arts during Trump’s second administration through productions and concerts that Americans actually want to see after years of the performing arts center running in the red. 

Trump named Grenell as his special presidential envoy for special missions to the United States in December before his inauguration, saying Grenell will ‘work in some of the hottest spots around the world, including Venezuela and North Korea.’

In this role, Grenell helped lead the administration through its response to the wildfires that tore through Southern California in the last days of the Biden administration through the beginning days of the Trump administration. 

Fox News Digital reached out to the White House for comment on the administration officials working multiple high-profile roles as opposed to appointing or nominating other qualified individuals but did not receive a response. 

This post appeared first on FOX NEWS

A group of investors sued UnitedHealthcare Group on Wednesday, accusing the company of misleading them after the killing of its CEO, Brian Thompson.

The class action lawsuit — filed in the Southern District of New York — accuses the health insurance company of not initially adjusting their 2025 net earning outlook to factor in how Thompson’s killing would affect their operations.

On Dec. 3 — a day before Thompson was fatally shot — the company issued guidance that included net earnings of $28.15 to $28.65 per share and adjusted net earnings of $29.50 to $30.00 per share, the suit notes. And on January 16, the company announced that it was sticking with its old forecast.

The investors described this as “materially false and misleading,” pointing to the immense public scrutiny the company and the broader health insurance industry experienced in the wake of Thompson’s killing.

The group, which is seeking unspecified damages, argued that the public backlash prevented the company from pursuing ‘the aggressive, anti-consumer tactics that it would need to achieve’ its earnings goals.

‘As such, the Company was deliberately reckless in doubling down on its previously issued guidance,’ the suit reads.

The company eventually revised its 2025 outlook on April 17, citing a needed shift in corporate strategy — a move that caused its stock to drop more than 22% that day.

‘The company denies any allegations of wrongdoing and intends to defend the matter vigorously,’ a UnitedHealthcare spokesperson said in a statement.

Thompson’s fatal shooting on the streets of New York City in broad daylight sent shockwaves across the nation.

Luigi Mangione, the 27-year-old man accused of the killing, has pleaded not guilty to federal and state charges against him. The legal defense fund for Mangione surpassed the $1 million mark in donations on Tuesday.

This post appeared first on NBC NEWS

Krispy Kreme stock plunged 24% on Thursday morning after the doughnut chain said it is “reassessing” its rollout with McDonald’s and pulled its full-year outlook in part due to economic “softness.”

Krispy Kreme is not planning to launch its doughnuts in any additional McDonald’s locations in the second quarter, suspending a nationwide rollout. As of March 30, more than 2,400 of the burger chain’s roughly 13,500 domestic locations carried Krispy Kreme doughnuts.

“I remain confident in the long-term national opportunity, but we need to work together with them to identify levers to improve sales,” Krispy Kreme CEO Josh Charlesworth said.

Over the last year, Krispy Kreme shares have shed more than 70% of their value, dragging the company’s market value down to less than $600 million.

Truist downgraded the stock on Thursday from buy to hold.

“We are shocked by the speed at which the story fell apart,” Truist analyst Bill Chappell wrote. ”… We no longer have high conviction in management’s previously stated strategy and execution of these initiatives, and it will likely take several quarters before we or investors can regain confidence.”

The two restaurant companies announced more than a year ago that Krispy Kreme doughnuts would be sold in all McDonald’s U.S. locations by the end of 2026. The rollout began roughly six months ago.

While the beginning phases were promising, sales fell below projections, Krispy Kreme executives said on Thursday.

As consumers worry about the broader economy and a potential recession, they have been pulling back their spending at restaurants. McDonald’s reported a 3.6% decline in its U.S. same-store sales for the first quarter. McDonald’s CEO Chris Kempczinski said that the fast-food industry’s traffic fell as middle- and low-income diners visited restaurants less frequently.

For Krispy Kreme, profitability appears to be the key reason for slowing the rollout with McDonald’s.

“However, we are seeing that after the initial marketing launch demand dropped below our expectations requiring intervention to deliver sustainable, profitable growth,” Charlesworth told analysts on the company’s conference call.

“We are partnering with McDonald’s to increase sales by stimulating higher demand and cutting costs by simplifying operations,” he added. “At the same time, we are reassessing our deployment schedule together with McDonald’s as we work to achieve a profitable business model for all parties.”

Krispy Kreme reported a net loss of $33 million for the quarter ended March 30.

To supply all of McDonald’s U.S. restaurants, Krispy Kreme was investing in expanding capacity quickly, which weighed on profits. In the last year, the company has reported three quarters of net losses.

The company uses a “hub and spoke” model that lets it make and distribute its treats efficiently. Production hubs, which are either stores or doughnut factories, send off freshly made doughnuts every day to retail locations such as grocery stores and gas stations. Krispy Kreme is looking to prune its unprofitable locations, which could affect up to 10% of its U.S. network.

Krispy Kreme also pulled its 2025 outlook, citing “macroeconomic softness” and uncertainty around the schedule for the McDonald’s partnership.

This post appeared first on NBC NEWS

The S&P 500 ($SPX) wrapped up Tuesday just below its intraday midpoint and posted one of the narrowest ranges we’ve seen in the past two months. That’s a clear sign traders are reluctant to take major bets ahead of Wednesday’s 2:00 PM ET Federal Open Market Committee (FOMC) decision.

And honestly, this caution makes sense. If we look back at how the stock market has reacted following the first two FOMC meetings of 2025, there has been a mix of hesitation and sharp moves.

Below is an updated chart marking each FOMC date since 2024 alongside the S&P 500. After the late January meeting, the S&P 500 zig-zagged to marginal new highs over the next two weeks before the first of two sharp down legs unfolded.

FIGURE 1. FOMC DATES SINCE 2024.

Coincidence or not, the S&P 500 is trading at nearly the same price level now, six weeks later, as it was back then. So, how close are today’s prices compared to the close on March 18, the day before the last Fed meeting?

This close (see chart below):

FIGURE 2. THE S&P 500 IS TRADING VERY CLOSE TO LAST FOMC MEETING LEVELS.

The difference is that the index has been rallying for four weeks, starting from the pivot low on April 7, a month ago today. In March, the S&P 500 was trying to bounce after topping four weeks earlier on February 19. That bounce continued for a few more days before dominant down-trending price action took over.

But over the last few weeks, the dominant trend is definitely higher. So the big question now is: can this mini uptrend resume after this pause?

A Short-Term Setup to Watch

A few days ago, the 14-period relative strength index (RSI) on the two-hour chart grazed the 70-overbought level for the first time since late January (see chart below). Yes, it took a nearly 18% rally in a very short time frame for it to finally happen, but remember, the indicator was coming off its lowest level since the COVID lows. Modest 3–5% pops were enough to trigger overbought readings for much of 2024. Not this time.

As you know, overbought conditions never persist, especially in very short timeframes like this. However, if this rally has anything left in the tank, we’ll see the indicator hit overbought again soon. That may not happen in the next day or two, but if the market reacts negatively to today’s news, but a bid returns soon after, it could keep some of the bullish patterns we’ve been tracking in play. That’s just one scenario, but one we’ll be closely watching.

FIGURE 3. TWO-HOUR CHART OF THE S&P 500.

Bullish Patterns Still Intact

There are two bullish pattern breakouts still in play on the S&P 500 chart:

And barring a very extreme and negative reaction, the patterns will stay alive today, as well.

FIGURE 4. INVERSE HEAD-AND-SHOULDERS AND CUP WITH HANDLE PATTERNS.

FIGURE 5. INVERSE HEAD-AND-SHOULDERS PATTERN IN THE S&P 500.

FIGURE 6. CUP WITH HANDLE PATTERN IN THE S&P 500.

A Bright Spot: Utilities

The Utilities Select Sector SPDR Fund (XLU) was the first sector ETF (and one of the first of all the ETFs we track) to notch a new 50-day high, which it hit on Tuesday. On the weekly chart, it’s clear the ETF is now trying to leverage a multi-month bottoming formation.

This is especially notable because the formation has developed above two bullish pattern breakouts from 2024. Ironically, XLU’s first major breakout of 2024 happened around this time last year (late April), which set the stage for an extremely strong run, at least through late November.

The current snapback is important to watch, given how well XLU has recently capitalized on bullish breakouts. Some upside follow-through from here would also put the former highs back in the crosshairs.

FIGURE 7. WEEKLY CHART OF UTILITIES SELECT SECTOR SPDR (XLU).

Invesco Solar (TAN) Still Has Work to Do

Invesco Solar ETF (TAN) has been rallying since the April lows, much like nearly every ETF we track. On the daily chart, it’s been trying to leverage a bullish cup and handle pattern, a formation we’ve also seen emerge in many other areas. It’s coming off an extremely oversold condition, with its 14-week RSI undercutting 30 for just the third time since 2021. So TAN could see some additional upside from here.

But the ETF will need to do much more to materially improve its long-term technical picture. Nearly every rally has stalled near the key weekly moving averages, all of which continue to slope lower. Selling strength in TAN has been a highly effective strategy since it peaked in early 2021.

FIGURE 8. WEEKLY CHART OF INVESCO SOLAR ETF (TAN).

Bitcoin Holding Up

Bitcoin has held its breakout from two weeks ago quite well so far. The next upside target remains near 103k. Again, regardless of whether or not you follow crypto, seeing the bid continue is a bullish sign for risk appetite across different asset classes, especially equities.

Fun fact: Bitcoin topped a few weeks before the SPX, so it can be a useful leading indicator.

FIGURE 9. BITCOIN BREAKS OUT.

Ethereum Playing Catch-Up

While Ethereum’s extreme relative weakness vs. Bitcoin has continued, it too has rallied over the last few weeks. It’s now close to breaking out from a cup with handle formation. At the same time, it’s testing its now flat 50-day moving average.

The combination of a bullish breakout and a move through the 50-day moving average produced a very strong follow-through rally in November, something Ethereum will try to replicate.

FIGURE 10. ETHEREUM BREAKS ABOVE 50-DAY MOVING AVERAGE.

Final Thoughts

As we head into the Fed decision, we’re seeing a lot of cautious optimism in the charts. Key bullish patterns are still holding, sectors like Utilities are showing strength, and crypto is flashing green.

The next few sessions will be important. If we get a knee-jerk reaction to the Fed, but buyers step in quickly it could set the stage for the next leg higher in this rally.

Stay alert.



Frank Cappelleri is the founder and president of CappThesis, an independent technical analysis newsletter firm. Previously, Frank spent 25 years on Wall Street, working for Instinet, the equity arm of Nomura and Smith Barney. Frank’s various roles included being an equity sales trader, technical analyst, research sales specialist and desk strategist. Frank holds the CFA and CMT designations and is a CNBC contributor.

https://cappthesis.com

https://www.youtube.com/@cappthesis

https://twitter.com/FrankCappelleri/

https://www.linkedin.com/in/frank-cappelleri-cfa-cmt-a319483/